Vanessa Pataia,  —

Articles by

AskBio Acquires BrainVectis and Potential Gene Therapy for Huntington’s

AskBio announced that it has acquired BrainVectis, a company developing gene therapies for Huntington’s disease and other neurodegenerative conditions. The two companies will work to advance BrainVectis’ gene therapy programs for neurodegenerative diseases associated with problematic fat metabolism in the brain, including a lead candidate therapy for Huntington’s called…